Shares of ENDRA Life Sciences Inc (NASDAQ:NDRA) shot up 9.4% during mid-day trading on Wednesday . The stock traded as high as $1.08 and last traded at $1.01, 310,463 shares traded hands during mid-day trading. An increase of 85% from the average session volume of 167,815 shares. The stock had previously closed at $0.92.
Several brokerages have recently issued reports on NDRA. Zacks Investment Research cut ENDRA Life Sciences from a “hold” rating to a “sell” rating in a report on Tuesday, November 19th. HC Wainwright reissued a “buy” rating and issued a $6.00 price objective on shares of ENDRA Life Sciences in a report on Monday, November 18th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $6.00.
The firm has a market cap of $7.59 million, a price-to-earnings ratio of -0.48 and a beta of 1.11. The company has a fifty day moving average price of $1.01 and a 200-day moving average price of $1.33. The company has a current ratio of 1.61, a quick ratio of 1.54 and a debt-to-equity ratio of 0.26.
ENDRA Life Sciences (NASDAQ:NDRA) last issued its quarterly earnings data on Wednesday, November 13th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.27). As a group, research analysts forecast that ENDRA Life Sciences Inc will post -0.98 earnings per share for the current fiscal year.
A hedge fund recently raised its stake in ENDRA Life Sciences stock. ICM Asset Management Inc. WA lifted its holdings in ENDRA Life Sciences Inc (NASDAQ:NDRA) by 3.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 696,201 shares of the company’s stock after purchasing an additional 21,875 shares during the period. ENDRA Life Sciences comprises about 0.9% of ICM Asset Management Inc. WA’s portfolio, making the stock its 29th largest holding. ICM Asset Management Inc. WA owned 10.50% of ENDRA Life Sciences worth $1,191,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 13.34% of the company’s stock.
About ENDRA Life Sciences (NASDAQ:NDRA)
ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding.
Featured Story: What are Institutional Investors?
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.